Table 1 Clinical characteristics of the participants
From: Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer
Variables | Cases, n (%) | Controls, n (%) | p-Value |
|---|---|---|---|
Total | 481 | 490 | |
Age (mean ± SD) | 65.55 ± 11.92 | 64.85 ± 11.83 | 0.694a |
>60 | 168 | 167 | 0.782b |
≤ 60 | 313 | 323 | |
Gender | |||
Male | 354(73.60) | 359(73.27) | 0.907 b |
Female | 127(26.40) | 131(26.73) | |
Drinking | |||
Yes | 53(11.02) | 47(9.59) | 0.465 b |
No | 428(88.98) | 443(90.41) | |
Smoking | |||
Yes | 111(23.08) | 119(24.29) | 0.658 b |
No | 370(76.92) | 371(75.71) | |
Helicobacter pylori infection status | |||
Positive | 262(54.47) | 241(49.18) | 0.099 b |
Negative | 219(45.53) | 249(50.81) | |
Differentiation | |||
Low | 195(40.54) | ||
Med and high | 286(59,46) | ||
Clinical stages | |||
T1-T2 | 159(33.06) | ||
T3-T4 | 322(66.94) | ||
Tumor Site | |||
GCA | 140(29.11) | ||
NGCA | 341(70.89) | ||